207 - If only US data is available for a particular disease, is that acceptable by PAAB?

  • In the absence of Canadian data for disease prevalence, PAAB will consider U.S. data providing it is a reasonable representation of the Canadian environment. An example where geography may differ significantly is microbial prevalence and susceptibility. PAAB will base its review of the data on the specific disease state. When deemed appropriate, the data should be based on recent authoritative consensus guidelines, recognized medical texts or primary epidemiology studies. The presentation of the data should clearly indicate the geographic location and date the data was obtained.